Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Chronic Renal Failure

Free Subscription Articles published in Nephrol Dial Transplant Retrieve available abstracts of 199 articles: HTML format

Single Articles

August 2026
1. ORTIZ A, Kramer A, Stel VS
   Over 500 000 people on kidney replacement therapy in the European Union.
   Nephrol Dial Transplant. 2026;41:1730-1735.
   PubMed     Abstract available
   
   
   
2. CASPER J, Doricic J, Tian Z, Willerding JM, et al
   Comparative Effectiveness of Combination Therapy in Patients with Chronic Kidney Disease and Diabetes mellitus Type 2 using Real World Data.
   Nephrol Dial Transplant. 2026 Aug 27:gfag198. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. 
   Expression of Concern: Dapagliflozin preserves kidney function and reduces albuminuria in children with chronic kidney disease.
   Nephrol Dial Transplant. 2026 Aug 27:gfag189. doi: 10.1093.
   PubMed    
   
   
   
4. MEPSCHEN M, Vos R, Herrington W, Provenzano M, et al
   Association of UACR and UPCR with kidney failure: a pooled analysis of clinical trials.
   Nephrol Dial Transplant. 2026;41.
   PubMed     Abstract available
   
   
   
5. ZOCCALI C, Kovesdy C, Mallamaci F, Winkelmayer WC, et al
   Chronic kidney disease, atrial fibrillation, and stroke: risk scores in the era of SGLT2i, non-steroidal MRA, and GLP-1 RA, and presence of high competing mortality.
   Nephrol Dial Transplant. 2026 Aug 20:gfag191. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. LOVSHIN JA
   Combination Pharmacotherapy in Type 2 Diabetes and Chronic Kidney Disease: Translating Evidence into Clinical Practice.
   Nephrol Dial Transplant. 2026 Aug 18:gfag136. doi: 10.1093.
   PubMed     Abstract available
   
   
   
7. SRITHARAN A, Marchetti M, Antiochos P, Iten L, et al
   Renin-Angiotensin System Inhibition in Dialysis-Dependent Patients with Chronic Heart Failure due to Reduced Ejection Fraction: A Systematic Review and Meta-Analysis.
   Nephrol Dial Transplant. 2026 Aug 12:gfag184. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. ASSADI F, Bidabadi E, Mazaheri M, Ghane-Sharbaf F, et al
   Dapagliflozin preserves kidney function and reduces albuminuria in children with chronic kidney disease.
   Nephrol Dial Transplant. 2026 Aug 6:gfag177. doi: 10.1093.
   PubMed     Abstract available
   
   
   July 2026
9. LENTINI P, Kashani K
   Beyond Diffusion and Convection: Is Adsorption the Third Dimension of Dialysis?
   Nephrol Dial Transplant. 2026 Jul 3:gfag156. doi: 10.1093.
   PubMed    
   
   
   June 2026
10. BEIGE J, Knoller S, Pachmann M, Sommer F, et al
    A website calculator to benchmark the carbon footprint of haemodialysis.
    Nephrol Dial Transplant. 2026;41:1294-1303.
    PubMed     Abstract available
    
    
    
11. BONTHUIS M, Kramer A, Bakkaloglu SA, Helve J, et al
    Incidence and prevalence of kidney replacement therapy in Central and Eastern Europe-trends from the ERA Registry.
    Nephrol Dial Transplant. 2026;41:1322-1339.
    PubMed     Abstract available
    
    
    
12. LIU JJ, Liu S, de Keizer J, Zheng H, et al
    Fasting urine osmolality and risk of kidney disease progression in patients with type 2 diabetes.
    Nephrol Dial Transplant. 2026;41:1304-1312.
    PubMed     Abstract available
    
    
    
13. TOYAMA T, Imaizumi T, Hamano T, Komaba H, et al
    Urinary protein vs albumin for assessing kidney failure risk in chronic kidney disease.
    Nephrol Dial Transplant. 2026 Jun 29:gfag122. doi: 10.1093.
    PubMed     Abstract available
    
    
    
14. 
    Correction to: Genetic testing in a national cohort of adults with chronic kidney disease of unknown origin.
    Nephrol Dial Transplant. 2026 Jun 22:gfag127. doi: 10.1093.
    PubMed    
    
    
    
15. 
    Correction to: Sex difference in cardiovascular risk in patients with chronic kidney disease: pooled analysis of four cohort studies.
    Nephrol Dial Transplant. 2026 Jun 18:gfag125. doi: 10.1093.
    PubMed    
    
    
    
16. KAHRAMAN KIZILCAOLUK BN, Pehlivan S
    A New Dimension in Hemodialysis: Integrating Art into Clinical Outcomes.
    Nephrol Dial Transplant. 2026 Jun 17:gfag143. doi: 10.1093.
    PubMed    
    
    
    
17. HOOGENBOOM LA, Hughes J, Ilori VA, Woodward S, et al
    A life course approach to preventing chronic kidney disease by limiting long-term consequences of early adverse events.
    Nephrol Dial Transplant. 2026 Jun 15:gfag133. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. 
    Correction to: Myocardial ischaemic syndromes in chronic kidney disease: risky pathways from non-acute to acute events.
    Nephrol Dial Transplant. 2026 Jun 10:gfag123. doi: 10.1093.
    PubMed    
    
    
    May 2026
19. VAN CRAENENBROECK AH, Chinnappa S, Dounousi E, Fernandez-Fernandez B, et al
    New kidneys, old risks: cardiovascular challenges after transplantation.
    Nephrol Dial Transplant. 2026;41:998-1010.
    PubMed     Abstract available
    
    
    
20. BOERSTRA BA, Kramer A, Jager KJ, Arnol M, et al
    Kidney replacement therapy trajectories of patients with kidney failure: an ERA Registry study.
    Nephrol Dial Transplant. 2026;41:1105-1117.
    PubMed     Abstract available
    
    
    
21. STEL VS, Chesnaye NC, Boenink R, Boerstra BA, et al
    Kidney replacement therapy for men and women according to the ERA Registry and the USRDS.
    Nephrol Dial Transplant. 2026;41:1082-1092.
    PubMed     Abstract available
    
    
    
22. IZQUIERDO-ORTIZ MJ, Gracia-Iguacel C, Hijazi-Prieto B, Hernandez-Tuda MDC, et al
    Sex, menopause and chronic kidney disease in primary care.
    Nephrol Dial Transplant. 2026 May 29:gfag110. doi: 10.1093.
    PubMed     Abstract available
    
    
    
23. HEERSPINK HJL, Fellstrom B, Wanner C, Gansevoort RT, et al
    Reconsidering the measurement of urinary proteins in chronic kidney disease: towards a global consensus on albuminuria assessment.
    Nephrol Dial Transplant. 2026 May 18:gfag112. doi: 10.1093.
    PubMed    
    
    
    
24. VIEIRA MB, Nicolau C, Curto A, Magrico R, et al
    Coffee consumption and chronic kidney disease.
    Nephrol Dial Transplant. 2026 May 12:gfag107. doi: 10.1093.
    PubMed     Abstract available
    
    
    
25. HUGHES A, Gonzalez AM, van Zwieten A, Guha C, et al
    Identifying strategies to improve life participation in children with chronic kidney disease: report from multinational SONG workshops.
    Nephrol Dial Transplant. 2026 May 9:gfag099. doi: 10.1093.
    PubMed     Abstract available
    
    
    
26. LU J, Zhou Y, Pang S, Lai R, et al
    Preemptive assessment of self-care ability increases choice for peritoneal dialysis in patients with kidney failure.
    Nephrol Dial Transplant. 2026 May 7:gfag105. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2026
27. TSENG MH, Sung CC, Cheng CJ, Tsai JD, et al
    Phenotype and renal outcomes of patients with congenital arginine vasopressin resistance.
    Nephrol Dial Transplant. 2026;41:909-918.
    PubMed     Abstract available
    
    
    
28. DORICIC J, Greite R, Brasen JH, Schmidt-Ott K, et al
    Neutrophil infiltration of kidney grafts: incidence, associated factors and graft survival.
    Nephrol Dial Transplant. 2026;41:919-929.
    PubMed     Abstract available
    
    
    
29. ZADORA W, Jacobs E, Lauriola M, Dejongh S, et al
    Intestinal Barrier Dysfunction in Chronic Kidney Disease: Evidence, Mechanisms, and its Potential Clinical Implications.
    Nephrol Dial Transplant. 2026 Apr 20:gfag082. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. IDOWU A, Lo KB, Mathew R, Navaneethan SD, et al
    Cardiovascular Outcomes and Acute Kidney Injury Risk with Combination Therapies in Type 2 Diabetes and Chronic Kidney Disease.
    Nephrol Dial Transplant. 2026 Apr 15:gfag087. doi: 10.1093.
    PubMed    
    
    
    March 2026
31. OMIC H, Mahdi-Nour-Ali Y, Hoffmann S, Abd El-Ghany K, et al
    Prevalence of Strongyloides stercoralis in haemodialysis patients in Vienna.
    Nephrol Dial Transplant. 2026;41:669-680.
    PubMed     Abstract available
    
    
    
32. MEKRAKSAKIT P, Vargas-Brochero MJ, Russo I, Buglioni A, et al
    Monoclonal gammopathy associates with kidney failure in ANCA-associated vasculitis.
    Nephrol Dial Transplant. 2026;41:692-702.
    PubMed     Abstract available
    
    
    
33. BAOUCHE H, Couchoud C, Moranne O, Kwon T, et al
    Children born to mothers receiving chronic dialysis, a national French cohort (2013-2021).
    Nephrol Dial Transplant. 2026 Mar 20:gfag029. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. MURUNGA S, Hofstetter J, Bayazit AK, Duzova A, et al
    Urinary Albumin-to-Creatinine Associates More Closely than Protein-to-Creatinine Ratio with Kidney Outcomes in Pediatric Chronic Kidney Disease.
    Nephrol Dial Transplant. 2026 Mar 14:gfag061. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. KIM JE, Kang D, Song SM, Kang MW, et al
    Clinical impact of ionized calcium and hidden hypocalcemia on cardiovascular outcomes in dialysis patients.
    Nephrol Dial Transplant. 2026 Mar 13:gfag057. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. ALAMO BS, Minguez I, Dominguez MED, Mendiola NR, et al
    The deleterous effect of proteinuria in residual kidney function in hemodialysis patients.
    Nephrol Dial Transplant. 2026 Mar 13:gfag058. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. REIS T, Cantaluppi V, Ostermann M, Brendolan A, et al
    Hemoadsorption Combined with Hemodialysis (HAHD): a Consensus Statement from an International Expert Panel.
    Nephrol Dial Transplant. 2026 Mar 3:gfag046. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2026
38. ORTIZ A, Lees JS, Torra R, Stel VS, et al
    The updated global burden of chronic kidney disease: one death every 20 seconds.
    Nephrol Dial Transplant. 2026 Feb 25:gfag040. doi: 10.1093.
    PubMed     Abstract available
    
    
    
39. DELANAYE P, van Londen M, Vidal-Petiot E, Masson I, et al
    Creatinine, cystatin C or both to estimate glomerular filtration rate in kidney transplant recipients?
    Nephrol Dial Transplant. 2026 Feb 19:gfag037. doi: 10.1093.
    PubMed     Abstract available
    
    
    
40. DAVIES M, Chiba S, van Hougenhouck-Tulleken W, Azzabi A, et al
    Kidney transplantation in Africa - workforce, capabilities, and perceived barriers.
    Nephrol Dial Transplant. 2026 Feb 18:gfag030. doi: 10.1093.
    PubMed     Abstract available
    
    
    
41. VELIOGLU A, Karagiannidis AG, Demir E, Hellemans R, et al
    Management of Antithrombotic Therapies in Kidney Transplantation Candidates and Recipients: An ERBP (European Renal Best Practice) Clinical Practice Document by the Descartes Working Group of the European Renal Association (ERA) and the Ekita Committe
    Nephrol Dial Transplant. 2026 Feb 9:gfag024. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2026
42. FOUQUE D, Koppe L
    Oil supplementation and cardiovascular mortality in the dialysis population.
    Nephrol Dial Transplant. 2026 Jan 28:gfag015. doi: 10.1093.
    PubMed    
    
    
    
43. DEL VECCHIO L, Cases A, Eisenga MF, Malyszko J, et al
    KDIGO 2026 clinical practice guideline for Anemia in Chronic Kidney Disease (CKD): a commentary from the European Renal Best Practice (ERBP).
    Nephrol Dial Transplant. 2026 Jan 28:gfag014. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. BOUWMANS P, Clase CM, Carrero JJ
    Drug stewardship for RAS-inhibitors and SGLT2-inhibitors in chronic kidney disease: stay on, restart.
    Nephrol Dial Transplant. 2026 Jan 22:gfag008. doi: 10.1093.
    PubMed     Abstract available
    
    
    
45. WANG Y, Zhu L, Yang Y, You Z, et al
    Association between body roundness index and all-cause and cardiovascular disease mortality in maintenance hemodialysis patients: evidence from a prospective cohort study in Southern China.
    Nephrol Dial Transplant. 2026 Jan 21:gfag006. doi: 10.1093.
    PubMed     Abstract available
    
    
    
46. RINCON-AREVALO H, Halleck F, Boger D, Rosenlehner E, et al
    RSVPreF3OA vaccine responses in kidney transplant recipients and dialysis patients versus healthy controls.
    Nephrol Dial Transplant. 2026 Jan 13:gfag002. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2025
47. MEIJERS B, Shroff R, Battaglia Y, Kazancioglu R, et al
    Medical device regulation and dialysis practice - impact on patients, doctors and manufacturers.
    Nephrol Dial Transplant. 2025 Dec 29:gfaf269. doi: 10.1093.
    PubMed     Abstract available
    
    
    
48. BELLIZZI V, Fordellone M, De Nicola L, Minutolo R, et al
    Cost-effectiveness of protein restricted diets in advanced CKD.
    Nephrol Dial Transplant. 2025;41:149-160.
    PubMed     Abstract available
    
    
    
49. MAUFRAIS C, Josse M, Patrier L, Isnard M, et al
    Cardioprotection from intradialytic exercise: a randomized trial.
    Nephrol Dial Transplant. 2025;41:67-78.
    PubMed     Abstract available
    
    
    
50. FERREIRA AC, Sezer S, Palladino G, Ortiz A, et al
    Safeguarding Innovation in Dialysis-Rethinking the EU Medical Device Regulation.
    Nephrol Dial Transplant. 2025 Dec 22:gfaf270. doi: 10.1093.
    PubMed    
    
    
    
51. MA LY, Tu YR, Chan MJ, Chan CI, et al
    The effect of icodextrin on peritoneal dialysis patients with congestive heart failure: a time-varying exposure design and target trial emulation approach.
    Nephrol Dial Transplant. 2025 Dec 13:gfaf265. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2025
52. CASAL MOURA M, Patricio-Liebana M, Zand L, Zubidat D, et al
    Sex-specific clinical presentations and outcomes in ANCA-associated vasculitis presenting with severe kidney disease.
    Nephrol Dial Transplant. 2025;40:2359-2371.
    PubMed     Abstract available
    
    
    
53. MIAO J, Zand J, Vaughan L, Soler MJ, et al
    Clinical phenotypes and renal outcomes in PLA2R-associated membranous nephropathy: a multi-center cohort study with unsupervised cluster analysis.
    Nephrol Dial Transplant. 2025;40:2309-2318.
    PubMed     Abstract available
    
    
    
54. ZHANG F, Huang L, Zhong Y
    Serum sodium levels and risk of all-cause mortality among hospitalized patients with chronic kidney disease.
    Nephrol Dial Transplant. 2025 Nov 26:gfaf255. doi: 10.1093.
    PubMed    
    
    
    
55. WOUDA RD, Karsten M, Michels EHA, Garrelds IM, et al
    Natriuretic Response to an Acute Oral Potassium Load in Healthy Individuals and Patients with Chronic Kidney Disease: A Randomized Controlled Trial.
    Nephrol Dial Transplant. 2025 Nov 25:gfaf238. doi: 10.1093.
    PubMed     Abstract available
    
    
    
56. KOPYTINA V, Marchant V, Rodrigues-Diez R, Pascual-Anton L, et al
    Troxerutin is a novel osmotic agent for peritoneal dialysis with protective cardiovascular actions.
    Nephrol Dial Transplant. 2025 Nov 13:gfaf249. doi: 10.1093.
    PubMed     Abstract available
    
    
    
57. YANG C, Liao B, Vart P, Johnson DW, et al
    Body roundness index and mortality risk in patients with chronic kidney disease: moving beyond the obesity paradox.
    Nephrol Dial Transplant. 2025 Nov 8:gfaf237. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2025
58. SATISH P, Smith R, Alasadi A, Frackiewicz E, et al
    A simple test of walking speed during transplant preassessment predicts positive cardiac investigations and mortality.
    Nephrol Dial Transplant. 2025;40:2159-2168.
    PubMed     Abstract available
    
    
    
59. SIM JJ, Chen Q, Cannizzaro N, Fernandes AW, et al
    CKD progression, kidney failure, and mortality among US patients with IgA nephropathy.
    Nephrol Dial Transplant. 2025;40:2104-2117.
    PubMed     Abstract available
    
    
    
60. VIRAMONTES-HORNER D, Stewart P, Stewart J, Taal MW, et al
    A novel system to continuously estimate intradialytic blood pressure in real time.
    Nephrol Dial Transplant. 2025;40:2074-2080.
    PubMed     Abstract available
    
    
    
61. MORALES E, Jenssen TG, Bevc S, Miglinas M, et al
    Obesity as a modifiable risk factor in patients with chronic kidney disease.
    Nephrol Dial Transplant. 2025 Oct 30:gfaf231. doi: 10.1093.
    PubMed     Abstract available
    
    
    
62. HEERSPINK HJL, van Raalte DH, Bjornstad P, Bunck MC, et al
    Rationale, Design, and Baseline Characteristics of the TRANSCEND-CKD trial of Retatrutide in Patients with Chronic Kidney Disease.
    Nephrol Dial Transplant. 2025 Oct 29:gfaf230. doi: 10.1093.
    PubMed     Abstract available
    
    
    
63. LOPEZ KC, Weidmann L, Harmacek D, Roessler F, et al
    Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation.
    Nephrol Dial Transplant. 2025 Oct 22:gfaf224. doi: 10.1093.
    PubMed     Abstract available
    
    
    
64. TIAN Z, Hillebrand UC, Casper J, Schmidt-Ott KM, et al
    Chronic kidney disease confers increased excess risks of mortality and cardiovascular events in women compared to men.
    Nephrol Dial Transplant. 2025 Oct 16:gfaf217. doi: 10.1093.
    PubMed     Abstract available
    
    
    
65. TEOH STY, Yap DYH, Tang CSO, Chan TM, et al
    Chronic Kidney Disease G3-5 in Lupus Nephritis - Prevalence, Progression, and Risk Factors.
    Nephrol Dial Transplant. 2025 Oct 3:gfaf201. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2025
66. CHUANG MH, Wang HY, Kan WC, Chien CC, et al
    Cardio-kidney outcomes for combined versus monotherapy with finerenone or SGLT2 inhibitors in patients with CKD.
    Nephrol Dial Transplant. 2025;40:1897-1905.
    PubMed     Abstract available
    
    
    
67. ANDRE DE LA RAMBELJE M, Beldhuis IE, Heerspink HJL, Greasley PJ, et al
    Protein profiles and associated biological pathways among different etiologies of chronic kidney disease: new insights from DAPA-CKD.
    Nephrol Dial Transplant. 2025 Sep 8:gfaf180. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2025
68. SLON-ROBLERO MF, Stel VS, Sanchez-Alvarez E, Escola JM, et al
    Trends in Home Dialysis Over the Last Decade in Europe: an ERA Registry Study.
    Nephrol Dial Transplant. 2025 Aug 29:gfaf171. doi: 10.1093.
    PubMed     Abstract available
    
    
    
69. ATIQUZZAMAN M, Er L, Djurdjev O, Zheng Y, et al
    COVID-19 infection and the progression of kidney disease in British Columbia, Canada.
    Nephrol Dial Transplant. 2025;40:1717-1726.
    PubMed     Abstract available
    
    
    
70. CASINO FG, Casino A, Herva ET, Basile C, et al
    New formulas for calculating dialysis dose in incremental haemodialysis.
    Nephrol Dial Transplant. 2025 Aug 7:gfaf147. doi: 10.1093.
    PubMed     Abstract available
    
    
    
71. BATTAGLIA Y, Shroff R, Meijers B, Nistor I, et al
    Haemodiafiltration versus high-flux haemodialysis-a Consensus Statement from the EuDial Working Group of the ERA.
    Nephrol Dial Transplant. 2025;40:1590-1614.
    PubMed     Abstract available
    
    
    
72. YAO YX, Tang C, Shi SF, Chen P, et al
    Red blood cell casts on kidney biopsy and progression of IgA nephropathy.
    Nephrol Dial Transplant. 2025;40:1570-1579.
    PubMed     Abstract available
    
    
    
73. YOSHIDA M, Maeoka Y, Takahashi A, Ishiuchi N, et al
    Effect of haemodiafiltration versus haemodialysis on vascular access patency when starting haemodialysis.
    Nephrol Dial Transplant. 2025;40:1538-1549.
    PubMed     Abstract available
    
    
    
74. PAGNIEZ MS, Fages V, Gatinois C, Larrue R, et al
    Exon location of glycine substitutions impacts kidney survival in autosomal dominant Alport syndrome.
    Nephrol Dial Transplant. 2025;40:1522-1530.
    PubMed     Abstract available
    
    
    July 2025
75. PERIS-FERNANDEZ M, Roca-Marugan MI, Viejo-Boyano I, Soldevila-Orient A, et al
    Hemodialysis removes protective metabolites and disrupts mitochondrial function.
    Nephrol Dial Transplant. 2025 Jul 31:gfaf145. doi: 10.1093.
    PubMed     Abstract available
    
    
    
76. ZOCCALI C, Chinnappa S, Fernandez-Fernandez B, Iatridi F, et al
    Myocardial Ischaemic Syndromes in Chronic Kidney Disease: Risky Pathways from Non-Acute to Acute Events.
    Nephrol Dial Transplant. 2025 Jul 30:gfaf142. doi: 10.1093.
    PubMed     Abstract available
    
    
    
77. AOUN M, Combe C, Jadoul M
    Life Support in Hemodialysis Emergencies - Treatment standard.
    Nephrol Dial Transplant. 2025 Jul 15:gfaf136. doi: 10.1093.
    PubMed     Abstract available
    
    
    
78. COX EF, Gullapudi VRL, Buchanan CE, White K, et al
    Effect of haemodialysis on the brain and heart assessed using multiparametric MRI.
    Nephrol Dial Transplant. 2025 Jul 9:gfaf117. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. BONIFANT G, Davis SN, Weir MR
    Treatment of diabetes in patients with advanced chronic kidney disease or kidney failure.
    Nephrol Dial Transplant. 2025 Jul 4:gfaf083. doi: 10.1093.
    PubMed     Abstract available
    
    
    
80. LAVILLE SM, Mouheb A, Massy ZA, Jacquelinet C, et al
    Male and female drug prescription patterns and adverse drug reactions in chronic kidney disease.
    Nephrol Dial Transplant. 2025 Jul 4:gfaf125. doi: 10.1093.
    PubMed     Abstract available
    
    
    
81. GUERRA JMA, Martinez-Martinez JI
    Multifactorial chronic kidney disease.
    Nephrol Dial Transplant. 2025 Jul 4:gfaf122. doi: 10.1093.
    PubMed     Abstract available
    
    
    
82. CHERNEY DZI, Belmar N, Bjornstad P, Chacko MM, et al
    Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease.
    Nephrol Dial Transplant. 2025 Jul 3:gfaf114. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2025
83. MARENGO M, Migliori M, Merlotti G, Naso E, et al
    High-flux hemodialysis with polymethylmethacrylate membranes reduces soluble CD40L, a mediator of cardiovascular disease in uremia.
    Nephrol Dial Transplant. 2025 Jun 6:gfaf101. doi: 10.1093.
    PubMed     Abstract available
    
    
    
84. 
    Correction to: Upcoming drug targets for kidney protective effects in chronic kidney disease.
    Nephrol Dial Transplant. 2025 Jun 5:gfaf099. doi: 10.1093.
    PubMed    
    
    
    
85. HALBRITTER J, Figueres L, Van Eerde AM, Capasso G, et al
    Chronic Kidney Disease of unexplained cause (CKDx): a consensus statement by the Genes & Kidney Working Group of the ERA.
    Nephrol Dial Transplant. 2025 Jun 3:gfaf092. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2025
86. WANG Z, Xiang W, Wang Y, Yu J, et al
    Patients with membranous lupus nephritis form two clusters with different prognoses.
    Nephrol Dial Transplant. 2025;40:1213-1224.
    PubMed     Abstract available
    
    
    
87. SHEN X, Chen P, Liu M, Liu L, et al
    Long-term outcomes of IgA nephropathy in China.
    Nephrol Dial Transplant. 2025;40:1137-1146.
    PubMed     Abstract available
    
    
    
88. MORALES E, Martin WP, Bevc S, Jenssen TG, et al
    How to individualise renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA.
    Nephrol Dial Transplant. 2025 May 13:gfaf069. doi: 10.1093.
    PubMed     Abstract available
    
    
    
89. ZOCCALI C, Lameire N, Ronco C, Carlson N, et al
    Acute kidney injury, acute kidney disease, and chronic kidney disease: challenges and research perspectives.
    Nephrol Dial Transplant. 2025 May 12:gfaf090. doi: 10.1093.
    PubMed     Abstract available
    
    
    
90. GLASSOCK RJ, Rule AD, Denic A, Delanaye P, et al
    KIDNEY AGING and CHRONIC KIDNEY DISEASE - Another Perspective.
    Nephrol Dial Transplant. 2025 May 7:gfaf087. doi: 10.1093.
    PubMed    
    
    
    
91. 
    Correction to: Global health inequalities of chronic kidney disease: a meta-analysis.
    Nephrol Dial Transplant. 2025 May 6:gfaf080. doi: 10.1093.
    PubMed    
    
    
    April 2025
92. QUENNEPOIX M, Koppe L, Bevier A, Barba C, et al
    Comparison of different heparin-free dialysis methods.
    Nephrol Dial Transplant. 2025 Apr 30:gfaf082. doi: 10.1093.
    PubMed    
    
    
    
93. SCHMIDT-LAUBER C, Thompson C, Schmidt EA, Klopp A, et al
    Prevalence and Characteristics of Chronic Kidney Disease in the Hamburg City Health Study.
    Nephrol Dial Transplant. 2025 Apr 30:gfaf075. doi: 10.1093.
    PubMed    
    
    
    
94. HAUPENTHAL F, Doberer K, Kapps S, Klager J, et al
    Self-reported Non-adherence to Immunosuppressive Medication Detected by the BAASIS Predicts Allograft Rejections in Kidney Transplant Recipients.
    Nephrol Dial Transplant. 2025 Apr 28:gfaf078. doi: 10.1093.
    PubMed     Abstract available
    
    
    
95. YEPES-CALDERON M, Martin Del Campo Sanchez F, Kremer D, Knobbe TJ, et al
    Plasma Trimethylamine N-oxide Concentration and All-Cause Mortality in Kidney Transplant Recipients.
    Nephrol Dial Transplant. 2025 Apr 24:gfaf071. doi: 10.1093.
    PubMed     Abstract available
    
    
    
96. DOLAN KJ, Gist KM, Basalely A, Bottari G, et al
    Functional outcomes in pediatric patients on renal replacement therapy in a worldwide registry.
    Nephrol Dial Transplant. 2025 Apr 21:gfaf067. doi: 10.1093.
    PubMed     Abstract available
    
    
    
97. KANBAY M, Abdel-Rahman SM, Brinza C, Ozbek L, et al
    A Meta-analysis of Graft Survival, Patient Survival, and Delayed Graft Function in First-Time and Repeat Kidney Transplants.
    Nephrol Dial Transplant. 2025 Apr 15:gfaf066. doi: 10.1093.
    PubMed     Abstract available
    
    
    
98. MONTEZ DE SOUSA IR, Bonthuis M, Kramer A, Ordonez FA, et al
    Adult outcomes of childhood kidney replacement therapy in Europe from 2008 to 2019: an ERA Registry study.
    Nephrol Dial Transplant. 2025;40:707-719.
    PubMed     Abstract available
    
    
    March 2025
99. AGRAWAL R, Waller JL, Baer SL, Bollag WB, et al
    Psoriaisis associates with increased risk for kidney transplant rejection.
    Nephrol Dial Transplant. 2025 Mar 26:gfaf047. doi: 10.1093.
    PubMed     Abstract available
    
    
    
100. ZHAO Y, Yang K, Nguyen CM, Wu H, et al
     Sex-specific cardiac dysfunction in mice with chronic kidney disease.
     Nephrol Dial Transplant. 2025 Mar 21:gfaf056. doi: 10.1093.
     PubMed     Abstract available
     
     
     
101. FERRO CJ, Wanner C, Luyckx V, Stevens K, et al
     ABCDE to identify and prevent chronic kidney disease: a call to action.
     Nephrol Dial Transplant. 2025 Mar 19:gfaf057. doi: 10.1093.
     PubMed     Abstract available
     
     
     
102. ANDRADE A, Bachmann M, Bobot M, Bruchfeld A, et al
     Cognitive impairment in chronic kidney disease: role of brain imaging, functional imaging, electroencephalography, cerebrospinal fluid biomarkers and sensors.
     Nephrol Dial Transplant. 2025;40.
     PubMed     Abstract available
     
     
     
103. PEPIN M, Giannakou K, Levassort H, Farinha A, et al
     Care pathways for patients with cognitive impairment and chronic kidney disease.
     Nephrol Dial Transplant. 2025;40.
     PubMed     Abstract available
     
     
     
104. ZHANG Y, Ye Z, Zhang Y, Yang S, et al
     Dietary vitamin E and tocopherol isoform intake and the progression of chronic kidney disease.
     Nephrol Dial Transplant. 2025 Mar 7:gfaf052. doi: 10.1093.
     PubMed     Abstract available
     
     
     
105. BAKKER WM, Heerspink HJL, Berger SP, Wanner C, et al
     Rationale and design of the Renal Lifecycle Trial assessing the Effect of Dapagliflozin on Cardiorenal Outcomes in Severe Chronic Kidney Disease.
     Nephrol Dial Transplant. 2025 Mar 7:gfaf046. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2025
106. URO-COSTE C, Lambert C, Audard V, Couzi L, et al
     Prophylactic treatment of FSGS recurrence in patients who relapsed on a previous kidney graft.
     Nephrol Dial Transplant. 2025;40:475-483.
     PubMed     Abstract available
     
     
     
107. PREKA E, Bonthuis M, Marks SD, Kramer A, et al
     Access to kidney transplantation and re-transplantation from childhood to adulthood: long-term data from the ERA Registry.
     Nephrol Dial Transplant. 2025 Feb 12:gfaf025. doi: 10.1093.
     PubMed     Abstract available
     
     
     
108. KANDURI SR, Badari A, Ullah F, Yang CW, et al
     Recovery from acute kidney injury treated with dialysis in patients with multiple myeloma treated with proteasome inhibitors.
     Nephrol Dial Transplant. 2025 Feb 7:gfaf028. doi: 10.1093.
     PubMed    
     
     
     
109. XU H, Eriksdotter M, Hafez G, Mitra S, et al
     Cholinergic system in patients with chronic kidney disease: cognitive and renal implications.
     Nephrol Dial Transplant. 2025 Feb 7:gfaf029. doi: 10.1093.
     PubMed     Abstract available
     
     
     
110. AGARWAL R, Green JB, Heerspink HJL, Mann JFE, et al
     COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: Baseline clinical characteristics.
     Nephrol Dial Transplant. 2025 Feb 7:gfaf022. doi: 10.1093.
     PubMed     Abstract available
     
     
     
111. WAGNER CA
     Beyond SGLT2: proximal tubule transporters as potential drug targets for chronic kidney disease.
     Nephrol Dial Transplant. 2025;40.
     PubMed     Abstract available
     
     
     
112. ALICIC RZ, Neumiller JJ, Tuttle KR
     Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease.
     Nephrol Dial Transplant. 2025;40.
     PubMed     Abstract available
     
     
     
113. NEUEN BL, Yeung EK, Rangaswami J, Vaduganathan M, et al
     Combination therapy as a new standard of care in diabetic and non-diabetic chronic kidney disease.
     Nephrol Dial Transplant. 2025;40.
     PubMed     Abstract available
     
     
     
114. ZHU D, Judge PK, Staplin N, Haynes R, et al
     Design considerations for future renoprotection trials in the era of multiple therapies for chronic kidney disease.
     Nephrol Dial Transplant. 2025;40.
     PubMed     Abstract available
     
     
     
115. NARDONE M, Yau K, Kugathasan L, Odutayo A, et al
     Upcoming drug targets for kidney protective effects in chronic kidney disease.
     Nephrol Dial Transplant. 2025;40.
     PubMed     Abstract available
     
     
     
116. MOEDT E, Wasehuus VS, Heerspink HJL
     Selective endothelin A receptor antagonism in chronic kidney disease: improving clinical application.
     Nephrol Dial Transplant. 2025;40.
     PubMed     Abstract available
     
     
     
117. CHEIKH HASSAN H, Tunnicliffe DJ, Loyd L, Mullan A, et al
     Kidney failure from kidney stones: an ANZDATA study.
     Nephrol Dial Transplant. 2025;40:320-328.
     PubMed     Abstract available
     
     
     January 2025
118. JORGENSEN HS, Vervloet M, Cavalier E, Bacchetta J, et al
     The role of nutritional vitamin D in CKD-MBD in children and adults with CKD, on dialysis and after kidney transplantation - a European consensus statement.
     Nephrol Dial Transplant. 2025 Jan 28:gfae293. doi: 10.1093.
     PubMed     Abstract available
     
     
     
119. TORINO C, Mallamaci F, Tripepi R, Mezzatesta S, et al
     The use of lung-ultrasound monitoring and the risk of intradialysis hypotension in hemodialysis patients: an analysis in the context of a randomized clinical trial.
     Nephrol Dial Transplant. 2025 Jan 27:gfaf015. doi: 10.1093.
     PubMed    
     
     
     
120. ZOCCALI C, Mallamaci F, Kanbay M, Tuttle KR, et al
     The Autonomic Nervous System and Inflammation in Chronic Kidney Disease.
     Nephrol Dial Transplant. 2025 Jan 27:gfaf020. doi: 10.1093.
     PubMed     Abstract available
     
     
     
121. YEN FS, Wei JC, Cheng WY, Huang CT, et al
     Low birth weight and chronic kidney disease with progression to kidney failure in children.
     Nephrol Dial Transplant. 2025 Jan 27:gfaf018. doi: 10.1093.
     PubMed     Abstract available
     
     
     December 2024
122. FRIEDRICH J, Bellmann M, Klank D, Porubsky S, et al
     Clinical and histological comparison of IgA nephritis and renal IgA vasculitis.
     Nephrol Dial Transplant. 2024;40:182-192.
     PubMed     Abstract available
     
     
     
123. BUTZ E, Schultheiss UT, Sekula P
     Modeling heterogeneity in the progression of chronic kidney disease.
     Nephrol Dial Transplant. 2024 Dec 19:gfae288. doi: 10.1093.
     PubMed     Abstract available
     
     
     
124. GANSEVOORT RT, Wheeler DC, Deben FM, Speeckaert M, et al
     The soluble guanylate cyclase activator runcaciguat significantly improves albuminuria in patients with chronic kidney disease: a randomized placebo-controlled clinical trial.
     Nephrol Dial Transplant. 2024 Dec 3:gfae261. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2024
125. AKIFOVA A, Budde K, Amann K, Buettner-Herold M, et al
     Donor-derived cell-free DNA monitoring for early diagnosis of antibody-mediated rejection after kidney transplantation: a randomized trial.
     Nephrol Dial Transplant. 2024 Nov 29:gfae282. doi: 10.1093.
     PubMed     Abstract available
     
     
     
126. HAHN LUNDSTROM U, Ramspek CL, Dekker FW, van Diepen M, et al
     Clinical impact of the Kidney Failure Risk Equation for vascular access planning.
     Nephrol Dial Transplant. 2024;39:2079-2087.
     PubMed     Abstract available
     
     
     
127. SUENAGA T, Tanaka S, Kitamura H, Tsuruya K, et al
     Estimated potassium intake and the progression of chronic kidney disease.
     Nephrol Dial Transplant. 2024 Nov 27:gfae277. doi: 10.1093.
     PubMed     Abstract available
     
     
     
128. DASGUPTA I, Meadowcroft AM, Bhatt PR, Acharya A, et al
     Efficacy and safety of daprodustat in patients on peritoneal dialysis in the ASCEND-D trial.
     Nephrol Dial Transplant. 2024 Nov 21:gfae273. doi: 10.1093.
     PubMed     Abstract available
     
     
     
129. DIETER RA, Mattoo A, Hotchkis P, Jaffe IS, et al
     Prophylactic 2-week Glecaprevir/Pibrentasvir in Hepatitis C positive to negative kidney transplantation.
     Nephrol Dial Transplant. 2024 Nov 20:gfae271. doi: 10.1093.
     PubMed     Abstract available
     
     
     
130. DE HAAN A, Eijgelsheim M, Vogt L, Hoorn EJ, et al
     Genetic testing in a national cohort of adults with chronic kidney disease of unknown origin.
     Nephrol Dial Transplant. 2024 Nov 19:gfae270. doi: 10.1093.
     PubMed     Abstract available
     
     
     
131. JOO YS, Yun HR, Kim HW, Koh HB, et al
     Smoking cessation and atherosclerotic cardiovascular events and mortality in chronic kidney disease.
     Nephrol Dial Transplant. 2024 Nov 15:gfae268. doi: 10.1093.
     PubMed     Abstract available
     
     
     
132. JUDGE PK, Tuttle KR, Staplin N, Hauske SJ, et al
     The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial.
     Nephrol Dial Transplant. 2024 Nov 12:gfae263. doi: 10.1093.
     PubMed     Abstract available
     
     
     
133. METSARINNE K, Bodegard J, Toppila I, Uusi-Rauva K, et al
     Characteristics, treatment and disease burden among stage 3-4 chronic kidney disease patients with and without type 2 diabetes in Finland during 2016-2022.
     Nephrol Dial Transplant. 2024 Nov 7:gfae242. doi: 10.1093.
     PubMed     Abstract available
     
     
     
134. ZIMMERMANN S, Mathew A, Bondareva O, Elwakiel A, et al
     Noncanonical microglial IL-1beta maturation in chronic kidney disease.
     Nephrol Dial Transplant. 2024 Nov 4:gfae239. doi: 10.1093.
     PubMed     Abstract available
     
     
     October 2024
135. KRAMER A, Jager KJ, Chesnaye NC, Kerschbaum J, et al
     Changes in the epidemiology of kidney replacement therapy across Europe in 2020-the first year of the COVID-19 pandemic: an ERA Registry study.
     Nephrol Dial Transplant. 2024;39:1835-1845.
     PubMed     Abstract available
     
     
     
136. NG MSY, Jones AT, Mallett AJ, O'Shaughnessy MM, et al
     Better kidney allograft survival despite higher-risk donor and recipient characteristics between 1995 and 2014.
     Nephrol Dial Transplant. 2024;39:1846-1855.
     PubMed     Abstract available
     
     
     
137. HAMROUN A, Aymes E, Couchoud C, Bechade C, et al
     Elderly predialysis care pathways and early morbidity-mortality upon start of dialysis.
     Nephrol Dial Transplant. 2024 Oct 18:gfae236. doi: 10.1093.
     PubMed     Abstract available
     
     
     
138. DUARTE MP, Nobrega OT, Vogt BP, Pereira MS, et al
     Reference Values for Handgrip Strength, Five Times Sit-to-stand, and Gait Speed in Patients on Hemodialysis.
     Nephrol Dial Transplant. 2024 Oct 16:gfae232. doi: 10.1093.
     PubMed     Abstract available
     
     
     
139. COHEN EP, Denic A, Aperna F, Mullan AF, et al
     Stenosis of the glomerulotubular neck in progressive chronic kidney disease.
     Nephrol Dial Transplant. 2024 Oct 16:gfae234. doi: 10.1093.
     PubMed     Abstract available
     
     
     
140. WAGNER CA, Massy ZA, Capasso G, Mattace-Raso F, et al
     Translational research on cognitive impairment in chronic kidney disease.
     Nephrol Dial Transplant. 2024 Oct 14:gfae229. doi: 10.1093.
     PubMed     Abstract available
     
     
     
141. ARDAVANI A, Curtis F, Hopwood E, Highton P, et al
     Effect of pharmacist interventions in chronic kidney disease: a meta-analysis.
     Nephrol Dial Transplant. 2024 Oct 9:gfae221. doi: 10.1093.
     PubMed     Abstract available
     
     
     
142. AN S, Qian H, Yang J, Han C, et al
     Cardiac magnetic resonance assessment of cardiac function across chronic kidney disease stages.
     Nephrol Dial Transplant. 2024 Oct 4:gfae222. doi: 10.1093.
     PubMed     Abstract available
     
     
     September 2024
143. BAE S, Chen Y, Sandal S, Lentine KL, et al
     Association of early steroid withdrawal with kidney transplant outcomes in first-transplant and retransplant recipients.
     Nephrol Dial Transplant. 2024 Sep 30:gfae218. doi: 10.1093.
     PubMed     Abstract available
     
     
     
144. ZHUANG B, Gan L, Liu B, Yuan W, et al
     Tolerability, safety and efficacy of a novel phosphate binder VS-505 (AP301): a Phase 2 dose-escalation and dose-ranging study in patients undergoing maintenance hemodialysis.
     Nephrol Dial Transplant. 2024;39:1649-1661.
     PubMed     Abstract available
     
     
     
145. STEL VS, Boenink R, Astley ME, Boerstra BA, et al
     A comparison of the epidemiology of kidney replacement therapy between Europe and the United States: 2021 data of the ERA Registry and the USRDS.
     Nephrol Dial Transplant. 2024;39:1593-1603.
     PubMed     Abstract available
     
     
     
146. OLIVERAS L, Rosales BM, De La Mata N, Vajdic CM, et al
     Relative survival in patients with cancer and kidney failure.
     Nephrol Dial Transplant. 2024;39:1604-1612.
     PubMed     Abstract available
     
     
     
147. IATRIDI F, Carrero JJ, Gall EC, Kanbay M, et al
     A commentary from the European Renal Best Practice (ERBP) on the Kidney Disease Improving Global Outcomes (KDIGO) 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease in children and adults.
     Nephrol Dial Transplant. 2024 Sep 19:gfae209. doi: 10.1093.
     PubMed     Abstract available
     
     
     
148. MAYNE KJ, Sardell RJ, Staplin N, Judge PK, et al
     Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.
     Nephrol Dial Transplant. 2024 Sep 14:gfae203. doi: 10.1093.
     PubMed     Abstract available
     
     
     
149. MAHBOOBI S, Mollard R, Tangri N, Askin N, et al
     Effects of dietary interventions for metabolic acidosis in chronic kidney disease: a systematic review and meta-analysis.
     Nephrol Dial Transplant. 2024 Sep 14:gfae200. doi: 10.1093.
     PubMed     Abstract available
     
     
     
150. ARANA C, Hermida E, Rovira J, Caro JL, et al
     Antibody-mediated rejection diagnosed in early protocol biopsies in high immunological risk kidney transplant recipients.
     Nephrol Dial Transplant. 2024 Sep 10:gfae186. doi: 10.1093.
     PubMed     Abstract available
     
     
     
151. VANHOLDER R, Bach D, Davies S, Finne P, et al
     Proactively boosting home dialysis adoption in Europe.
     Nephrol Dial Transplant. 2024 Sep 9:gfae199. doi: 10.1093.
     PubMed    
     
     
     
152. CHO Y, Cullis B, Ethier I, Htay H, et al
     Global structures, practices, and tools for provision of chronic peritoneal dialysis.
     Nephrol Dial Transplant. 2024;39.
     PubMed     Abstract available
     
     
     
153. HTAY H, Cho Y, Jha V, See E, et al
     Global structures, practices, and tools for provision of hemodialysis.
     Nephrol Dial Transplant. 2024;39.
     PubMed     Abstract available
     
     
     
154. VIECELLI AK, Gately R, Barday Z, Shojai S, et al
     Worldwide organization and structures for kidney transplantation services.
     Nephrol Dial Transplant. 2024;39.
     PubMed     Abstract available
     
     
     August 2024
155. ZHANG LY, Dinh A, Johansen KL, McCulloch CE, et al
     Access to kidney transplantation from dialysis facilities affiliated with a transplant center versus free-standing dialysis facilities in the US.
     Nephrol Dial Transplant. 2024 Aug 30:gfae194. doi: 10.1093.
     PubMed    
     
     
     
156. ALUND O, Unwin R, Challis B, Kalra PA, et al
     A note on performance metrics for the Kidney Failure Risk Equation.
     Nephrol Dial Transplant. 2024;39:1523-1525.
     PubMed    
     
     
     
157. SACHEZ-ALAMO B, Moi L, Bajema I, Berden A, et al
     Long-term outcome of kidney function in patients with ANCA-associated vasculitis.
     Nephrol Dial Transplant. 2024;39:1483-1493.
     PubMed     Abstract available
     
     
     
158. QUIROGA B, Diez J
     The kidney-skeletal muscle-heart axis in chronic kidney disease: implications for myokines.
     Nephrol Dial Transplant. 2024 Aug 30:gfae193. doi: 10.1093.
     PubMed     Abstract available
     
     
     
159. PANIAGUA R, Ramos A, Avila M, Ventura MD, et al
     Remote monitoring of automated peritoneal dialysis reduces mortality, adverse events, and hospitalizations: a cluster randomized controlled trial.
     Nephrol Dial Transplant. 2024 Aug 20:gfae188. doi: 10.1093.
     PubMed     Abstract available
     
     
     
160. SCHROPPEL B, Bettac L, Schulte-Kemna L, Kachele M, et al
     Placement of tunneled hemodialysis catheters - interventional standard.
     Nephrol Dial Transplant. 2024 Aug 16:gfae181. doi: 10.1093.
     PubMed     Abstract available
     
     
     
161. GROSS O, Boeckhaus J, Weber LT, Heerspink HJL, et al
     Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in pediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport.
     Nephrol Dial Transplant. 2024 Aug 9:gfae180. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2024
162. DONG Y, Wang Z, Guo W, Zhu L, et al
     Association between urinary C4d levels and disease progression in IgA nephropathy.
     Nephrol Dial Transplant. 2024;39:1279-1287.
     PubMed     Abstract available
     
     
     
163. KOMMER A, Kostev K, Schleicher EM, Weinmann-Menke J, et al
     Proton pump inhibitor use and bone fractures in patients with chronic kidney disease.
     Nephrol Dial Transplant. 2024 Jul 18:gfae135. doi: 10.1093.
     PubMed     Abstract available
     
     
     
164. LI Z, Chen S, Tan Y, Lv J, et al
     The effect of preeclampsia on long-term kidney function among pregnant women with chronic kidney disease.
     Nephrol Dial Transplant. 2024 Jul 17:gfae172. doi: 10.1093.
     PubMed     Abstract available
     
     
     
165. MAKHLOUFI M, Cottinet PJ, Ranchin B, Dureuil B, et al
     Hemodialysis versus peritoneal dialysis in children: an eco-audit.
     Nephrol Dial Transplant. 2024 Jul 13:gfae159. doi: 10.1093.
     PubMed    
     
     
     
166. COLLISTER D, Pyne L, Bhasin AA, Smyth B, et al
     Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study.
     Nephrol Dial Transplant. 2024 Jul 10:gfae156. doi: 10.1093.
     PubMed     Abstract available
     
     
     
167. FAGUER S, Serre JE, Brusq C, Bongard V, et al
     A randomized crossover trial of regional anticoagulation modalities for intermittent hemodialysis.
     Nephrol Dial Transplant. 2024 Jul 8:gfae155. doi: 10.1093.
     PubMed     Abstract available
     
     
     
168. GHIMIRE A, Lloyd AM, Bello AK, Battistella M, et al
     Prescribing patterns and medications costs in patients on maintenance hemodialysis and peritoneal dialysis.
     Nephrol Dial Transplant. 2024 Jul 4:gfae154. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2024
169. BOGATAJ S, Roelands B, Pajek M, Pajek J, et al
     Intradialytic cycling and cognitive training to mitigate decreased functional and physiological status in haemodialysis patients.
     Nephrol Dial Transplant. 2024;39:1198-1200.
     PubMed    
     
     
     
170. KIM JE, Park J, Jang Y, Kang E, et al
     Oral phosphate binders and incident osteoporotic fracture in patients on dialysis.
     Nephrol Dial Transplant. 2024 Jun 17:gfae139. doi: 10.1093.
     PubMed     Abstract available
     
     
     
171. HEERSPINK HJL, Agarwal R, Bakris GL, Cherney DZI, et al
     Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.
     Nephrol Dial Transplant. 2024 Jun 11:gfae132. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2024
172. BATTAGLIA Y, Mantovani A, Shroff R, Alfano G, et al
     Online haemodiafiltration and all-cause mortality: how fragile are the results of the studies published so far?
     Nephrol Dial Transplant. 2024;39:1034-1036.
     PubMed    
     
     
     
173. LABRIOLA L, Crott R, Desmet C, Romain C, et al
     Infectious complications associated with buttonhole cannulation of native arteriovenous fistulas: a 22-year follow-up.
     Nephrol Dial Transplant. 2024;39:1000-1007.
     PubMed     Abstract available
     
     
     
174. CORTE-IGLESIAS V, Saiz ML, Andrade-Lopez AC, Salazar N, et al
     Propionate and butyrate counteract renal damage and progression to chronic kidney disease.
     Nephrol Dial Transplant. 2024 May 24:gfae118. doi: 10.1093.
     PubMed     Abstract available
     
     
     
175. VANHOLDER R, Bach D, Davies S, Finne P, et al
     Unlocking the Untapped Potential: The Neglected Home Dialysis Assets in Europe.
     Nephrol Dial Transplant. 2024 May 16:gfae111. doi: 10.1093.
     PubMed    
     
     
     
176. KREMER D, Salamah S, Groothof D, Post A, et al
     Plasma Symmetric Dimethylarginine and Kidney Graft Function in Kidney Transplant Recipients.
     Nephrol Dial Transplant. 2024 May 15:gfae109. doi: 10.1093.
     PubMed    
     
     
     
177. MCEWAN P, Gabb PD, Davis JA, Sanchez JJG, et al
     The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis.
     Nephrol Dial Transplant. 2024 May 10:gfae106. doi: 10.1093.
     PubMed     Abstract available
     
     
     
178. KRAMER A, Boenink R, Mercado Vergara CG, Bell S, et al
     Time trends in preemptive kidney transplantation in Europe: an era registry study.
     Nephrol Dial Transplant. 2024 May 9:gfae105. doi: 10.1093.
     PubMed     Abstract available
     
     
     
179. IATRIDI F, Malandris K, Ekart R, Xagas E, et al
     Low dialysate sodium and 48-h ambulatory blood pressure in patients with intradialytic hypertension: a randomized crossover study.
     Nephrol Dial Transplant. 2024 May 6:gfae104. doi: 10.1093.
     PubMed     Abstract available
     
     
     April 2024
180. WOLFGRAM DF, Richerson WT, Murray AM, Schmit BD, et al
     Cognitive deficits associate with cerebral hypoxia during hemodialysis.
     Nephrol Dial Transplant. 2024 Apr 30:gfae101. doi: 10.1093.
     PubMed    
     
     
     
181. LEMOINE S, Akbari A, Brahm G, Dorie J, et al
     Redefining the concept of residual renal function with kidney sodium MRI: a pilot study.
     Nephrol Dial Transplant. 2024 Apr 30:gfae070. doi: 10.1093.
     PubMed     Abstract available
     
     
     
182. KANBAY M, Basile C, Battaglia Y, Mantovani A, et al
     Shared decision making in elderly patients with kidney failure.
     Nephrol Dial Transplant. 2024;39:742-751.
     PubMed     Abstract available
     
     
     
183. LIAO YR, Tsai YC, Hsieh TH, Tsai MT, et al
     FHL2 in arterial medial calcification in chronic kidney disease.
     Nephrol Dial Transplant. 2024 Apr 25:gfae091. doi: 10.1093.
     PubMed     Abstract available
     
     
     
184. LOMBARDI G, Ferraro PM, De Tomi E, Bargagli M, et al
     Sex differences in chronic kidney disease-related complications and mortality across levels of glomerular filtration rate.
     Nephrol Dial Transplant. 2024 Apr 17:gfae087. doi: 10.1093.
     PubMed     Abstract available
     
     
     
185. ZHANG X, Wang G, Li M, Li Y, et al
     Both partial inactivation as well as activation of NF-kappaB signaling lead to hypertension and chronic kidney disease.
     Nephrol Dial Transplant. 2024 Apr 13:gfae090. doi: 10.1093.
     PubMed     Abstract available
     
     
     
186. 
     Correction to: Associations of neutral pH, low-GDP peritoneal dialysis solutions with patient survival, transfer to haemodialysis and peritonitis.
     Nephrol Dial Transplant. 2024 Apr 10:gfae073. doi: 10.1093.
     PubMed    
     
     
     
187. STOUMPOS S, Crowe K, Sarafidis P, Barratt J, et al
     Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a document by the European Renal Best Practice board of the European Renal Association.
     Nephrol Dial Transplant. 2024 Apr 4:gfae075. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2024
188. ELEFTHERIADIS G, Naik MG, Osmanodja B, Halleck F, et al
     Office or home versus 24-hour blood pressure measurement in stable kidney transplant recipients.
     Nephrol Dial Transplant. 2024 Mar 28:gfae076. doi: 10.1093.
     PubMed     Abstract available
     
     
     
189. WINDAHL K, Chesnaye NC, Irving GF, Stenvinkel P, et al
     The safety of a low protein diet in older adults with advanced chronic kidney disease.
     Nephrol Dial Transplant. 2024 Mar 27:gfae077. doi: 10.1093.
     PubMed     Abstract available
     
     
     
190. FORBES AK, Hinton W, Feher MD, Elson W, et al
     A Comparison of Sodium-Glucose Co-Transporter 2 Inhibitor Kidney Outcome Trial Participants with a Real-World Chronic Kidney Disease Primary Care Population.
     Nephrol Dial Transplant. 2024 Mar 22:gfae071. doi: 10.1093.
     PubMed     Abstract available
     
     
     
191. VALENZUELA PL, Castillo-Garcia A, Saco-Ledo G, Santos-Lozano A, et al
     Physical exercise: a polypill against chronic kidney disease.
     Nephrol Dial Transplant. 2024 Mar 9:gfae062. doi: 10.1093.
     PubMed     Abstract available
     
     
     
192. ZHAI S, Liu D, Liu H, Li W, et al
     Cold atmospheric plasma for chronic kidney disease-related skin disorders.
     Nephrol Dial Transplant. 2024 Mar 1:gfae057. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2024
193. VAN OEVELEN M, Bonenkamp AA, van Eck van der Sluijs A, Bos WJW, et al
     Health-related quality of life and symptom burden in patients on haemodialysis.
     Nephrol Dial Transplant. 2024;39:436-444.
     PubMed     Abstract available
     
     
     
194. AKERBOOM B, Janse RJ, Caldinelli A, Lindholm B, et al
     A tool to predict the risk of lower extremity amputation in patients starting dialysis.
     Nephrol Dial Transplant. 2024 Feb 26:gfae050. doi: 10.1093.
     PubMed     Abstract available
     
     
     
195. KUNUTSOR SK, Dey RS, Touw DJ, Bakker SJL, et al
     Urine cotinine versus self-reported smoking and the risk of chronic kidney disease.
     Nephrol Dial Transplant. 2024 Feb 24:gfae054. doi: 10.1093.
     PubMed     Abstract available
     
     
     
196. VERZOLA D, Saio M, Milanesi S, Picciotto D, et al
     Altered adiponectin regulation in skeletal muscle of patients with chronic kidney disease.
     Nephrol Dial Transplant. 2024 Feb 23:gfae051. doi: 10.1093.
     PubMed    
     
     
     
197. ADOLI LK, Couchoud C, Chatelet V, Lobbedez T, et al
     Lower access to kidney transplantation for women in France is not explained by comorbidities and social deprivation.
     Nephrol Dial Transplant. 2024 Feb 21:gfae047. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2023
198. DE LA MATA NL, Khou V, Hedley JA, Kelly PJ, et al
     Journey to kidney transplantation: patient dynamics, suspensions, transplantation and deaths in the Australian kidney transplant waitlist.
     Nephrol Dial Transplant. 2023 Nov 28:gfad253. doi: 10.1093.
     PubMed     Abstract available
     
     
     
199. HARDING JL, Di M, Pastan SO, Doucet N, et al
     Examination of Sex/Gender Disparities Across the Continuum of Kidney Transplant Steps.
     Nephrol Dial Transplant. 2023 Nov 9:gfad242. doi: 10.1093.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum